The Mammogram Myth, Alive and Well on Good Morning America

“Good Morning America”'s Amy Robach. (Ida Mae Astute/ AP Photo/ ABC)

“Good Morning America’s” Amy Robach (Ida Mae Astute/ AP Photo/ ABC)

Good Morning America correspondent Amy Robach announced on November 11th that the on-air mammogram she had in front of millions as part of Good Morning America’s month-long breast cancer awareness promotion, ended up getting her a breast cancer diagnosis. Although there are no details about the diagnosis (biology, staging, potential spread), Robach says she “got lucky by catching it early” and hopes her story will “inspire every woman who hears it to get a mammogram, to take a self exam. No excuses. It is the difference between life and death.”

It remains to be seen whether Robach’s mammogram really will make a life-saving difference, whether her cancer was truly found early, and if so, whether it is the type of cancer that, when treated properly and successfully, will result in a normal life expectancy.

An ideal screening intervention focuses on detection of disease that will “ultimately cause harm, is more likely to be cured if detected early, and for which curative treatments are more effective in early-stage disease.” Unfortunately, this is not always the case. The main issue is that breast cancer is not one disease. There are at least ten molecular types each with different prognoses. Breast cancer’s biological complexity coupled with the limitations of x-rays and computer-aided technologies to see cancers clearly and the differences in expertise among radiologists and diagnostic centers to make sense of them, make it hard to say with any degree of certainty that a mammogram saved anyone’s particular life.

There is a growing consensus that universal screening saves far fewer lives than people think. Dr. Otis Brawley, chief medical officer of the American Cancer Society has said on numerous occasions that, “American medicine has overpromised when it comes to screening. The advantages to screening have been exaggerated.” Nonetheless 40-year-old Robach, who immediately scheduled a bilateral mastectomy (an aggressive intervention found to be unnecessary in most cases), counts her life among those saved.

The Rise of the On-Air Health Screening

Amy Robach’s agreement to have the “first ever live television mammogram” follows a relatively recent trend of TV personalities getting on-air health checkups. Katie Couric’s live colonoscopy on NBC’sToday show in March 2000 was the first. A study published in the Journal of the American Medical Association found that Couric’s televised colon cancer awareness campaign was temporally associated with an increase in colonoscopy use in 2 different data sets. The demonstrated “Couric-effect” encouraged other shows to use celebrity spokespersons to encourage public participation in select health based initiatives.

NBC Today show anchors Matt Lauer and Al Roker recently had digital rectal exams, behind closed doors, on live TV as part of the show’s initiative “to raise awareness for men’s health issues.” Health News Review pointed out several problems with the segment, including conflicts of interest, misleading health information, and the overzealous promise of the lives to be saved along with the omission of associated risks and complications. The trend toward infotainment rather than balanced and accurate discussion of the potential benefits and potential harms of mass screening repeats in Good Morning America‘s focus on the unequivocal belief that Robach’s on-air mammogram will save lives. And now, using the erroneous conclusion that a single data point represents a trend, Robach’s resultant treatment for breast cancer seems to support the idea that she’s one of them. Robach may indeed be one of them. She won’t know for sure for many years. But beyond the dramatic story of the single data point, there is an entire body of evidence that suggests otherwise.

Following hundreds of thousands of women over long periods of time, randomized clinical trials have found that very few women, only about 15 percent, have their lives saved by routine mammogram screenings. Some studies put the screening-associated reduction as low as two percent. The problem is that some breast cancers don’t show up well on mammograms, or at all; some cancers, even though they may be small, have already spread throughout the body; and some of the most aggressive types of breast cancer show up between mammograms.

Although increased screening has led to an emphasis on early detection as the way to reduce cancer deaths, universal screening has not translated into a reduction in the number of invasive cancers (i.e., the types that have the capacity to spread and cause death). With rates of recurrence at 20 to 30 percent even 15 years or longer after diagnosis, an average prognosis of only one to three years for people whose cancer has spread to distant organs, and approximately 40 thousand deaths from the disease year after year, “early detection” does not accurately describe the scenario for most breast cancers. Yet, the seemingly unequivocal and unwavering support of some doctors, celebrities, radiology centers, and professional mouthpieces still promote a one-size-fits-all approach to breast cancer screening even when they fail to support diagnostic mammograms (i.e., those used to help make a diagnosis once signs or symptoms have already appeared).

Breast Cancer’s False Narrative

Stories about Amy Robach’s on-air mammogram and public reveal mirror breast cancer’s false narrative that “Every cancer is curable as long as you catch it in time.” Epitomized by the phrase, “That mammogram just saved your life,” the idea that early detection via screening is the key to survival is a misleading overstatement, one that reverberates in an awareness inspired echo chamber especially during the month of October. Professors Steven Woloshin, MD, and Lisa M. Schwartz, MD, of the Department of Veterans Affairs Medical Center and the Dartmouth Institute for Health Policy and Clinical Practice, published an essay in British Medical Journal criticizing advertisements (notably those from the wealthiest breast cancer charity in the world, Susan G. Komen [for the cure]) that play into the false narrative by exaggerating and distorting medical information to sell wholesale mammography screening. Yet, the mammogram “get screened now” mantra resounds even though Komen’s chief scientific advisor Dr. Eric Winer admitted that “We have oversold mammography to the American public.”

The body of evidence does not support universal screening; it supports individualized informed decision making based on specific benefits and harms. The 2009 recommendation from the United States Preventive Services Task Force against universal screening mammography for women aged 40 to 49 recognized the limitations of this popular diagnostic tool in reducing deaths from breast cancer. The updated systematic review of randomized, controlled trials with 10 or more years of follow-up also found evidence of harm from universal screening, as it leads to overdiagnosis and overtreatment. This admission and change in recommendations continually sets off a flurry of disagreements among doctors and professional associations alike. Yet the evidence continues to mount that universal mammography screening overpromises and underdelivers.

In particular, screening has increased the number of cases of “indolent/precancerous” tumors which, according to a working group of the National Cancer Institute, tend to be potentially clinically insignificant. Instead of finding the aggressive cancers that are the most life threatening, one in five breast cancer diagnoses fall into the stage zero/precancer category. Treating these conditions has not led to a decrease in late stage disease as would be expected if they were all early indicators of invasive cancer. The working group sees this flaw in screening as an opportunity for improvement.

“Going forward, the ability to design better screening programs will depend on the ability to better characterize the biology of the disease detected and to use disease dynamics (behavior over time) and molecular diagnostics that determine whether cancer will be aggressive or indolent to avoid overtreatment.  . . . Physicians, patients, and the general public must recognize that overdiagnosis is common and occurs more frequently with screening.”

The group also implores the media to “better understand and communicate the message so that as a community the approach to screening can be improved.”

Will Amy Robach’s oft-tweeted personal story on morning television open the public discussion about the need for better screening programs? Will it foster a deeper understanding of which breast conditions will benefit from treatment, thereby reducing deaths, and which will not? Will it help individual women weigh the potential benefits and the potential harms of universal screening in terms of overdiagnosis and overtreatment? Or will Robach’s story, as a “walking example” of how “having a mammogram saved my life,” give greater social force to breast cancer’s false narrative? Will it end up, in the long run, confusing the public even more about the complexities and limitations of universal mammography screening?

Amos Zeeberg, digital editor of Nautilus, put it this way: “The surprising inefficiency of mammograms doesn’t mean they need to end, but that they should be reasonably evaluated, not treated as our divine shield against cancer, administered to everyone with breasts, and paired unquestioningly with the most aggressive treatments available.” I hope the producers of Good Morning America are listening, Amos.

This essay was originally published on Psychology Today, November 14, 2013. Excerpts from this essay were quoted in the Minnesota Post.

Be Sociable, Share!

2 comments to The Mammogram Myth, Alive and Well on Good Morning America

  • Ruth

    After reading this article, I feel at a loss about what to do. If my doctor’s recommendation to have yearly screenings is not reliable, how am I to track whether I am developing a tumor?

  • Here is a good piece by H.G. Welch on the early detection/screening issue that makes a lot of sense to me. http://www.nytimes.com/2012/11/22/opinion/cancer-survivor-or-victim-of-overdiagnosis.html?_r=0 “There’s good news here, too: breast cancer mortality has fallen substantially in the United States and Europe. But it’s not about screening. It’s about treatment. Our therapies for breast cancer are simply better than they were 30 years ago. As treatment improves, the benefit of screening diminishes. Think about it: because we can treat most patients who develop pneumonia, there’s little benefit to trying to detect pneumonia early. That’s why we don’t screen for pneumonia. So here is what we now know: the mortality benefit of mammography is much smaller, and the harm of overdiagnosis much larger, than has been previously recognized. But to be honest, that general message has been around for more than a decade. Why isn’t it getting more traction? The reason is that no other medical test has been as aggressively promoted as mammograms. . . . What should be done? First and foremost, tell the truth: woman really do have a choice. While no one can dismiss the possibility that screening may help a tiny number of women, there’s no doubt that it leads many, many more to be treated for breast cancer unnecessarily.”

    There is also a “risk calculator” from the National Cancer Institute to estimate your risk of developing breast cancer based on key factors shown to increase risk. http://www.cancer.gov/bcrisktool/Default.aspx This information could be useful to discuss with your doctor.

To speak her truth, she needed to give her words and identity away, to a trusted poet and friend @stevedavenport breastcancerconsortium.net/ov…

“Pink Ribbon Blues”

Paperback includes a new Introduction on fundraising controversies and a color insert with images of, and reactions to, the pinking of breast cancer (2012).


Praise » 

Flyer »

Press Release »

Hardback Cover »

Paperback Cover »

Request Review Copies »

Order the Paperback »

* GAYLE IN THE MEDIA *

"Seeing clearly through the pink haze" Toronto Sun

*Sad face*: Being happy does not help you live longer" New Scientist

How should we address breast cancer when norms continually change? The Guardian

Your Fun 'No Bra Day' Photos Are Overshadowing Terminal Breast Cancer Patients Broadly

Backlash against “pinkwashing” of breast cancer awareness campaigns BMJ

Breast Cancer to Rise 50 Percent by 2030? Hey, Not So Fast! Health News Review

Breast Cancer: The Flaws in the Cause iafrica.com

How to Make the Biggest Impact With Your Breast Cancer Donations Money

The Very Pink, Very Controversial Business of Breast Cancer Awareness Racked

NFL, Pink Ribbons Not Enough to Win over Women CNN

3 Questions We Need to Answer for Breast Cancer Awareness Month Chronicle of Philanthropy

The problem with National Breast Cancer Awareness Month Women's Health Magazine

Pink Ribbon Envy: Living with an Uncool Cancer The Nib

A Year After Bombings, Some Say 'Boston Strong' Has Gone Overboard NPR, All Things Considered

Canadian Mammogram Study KCRW, NPR Affiliate

Time to Debunk the Mammography Myth CNN

Breast Cancer: Awareness, Activism & Pinkwashing NPR Charlotte

Buying Pink Al Jazeera's The Stream Watch »

The Pink Backlash Orlando Sentinel

Why Jolie's Test Costs So Much CNN

Preventative Mastectomies: Disease and Deception BlogTalkRadio

Angelina Jolie and the 'Breast Cancer Gene' KCRW

Our Feel-Good War on Breast Cancer The New York Times Magazine.

The Story Behind the Pink Ribbon Campaign Sisters Talk Radio

WISH Interview Women's International Summit for Health

Making Cancer About The Patient, Not The Body Part CBS Pittsburgh

Sexy breast cancer campaigns anger many patients USA Today

The perils of pink The Daily

Komen pink campaign creates breast-cancer blues for some Dallas Morning News

A yellow flag for the NFL's pink New York Daily

Gayle Sulik named #7 in SharecareNow’s Top 10 Online Influencers in Breast Cancer

Breast cancer cancer causes so easily derailed Philly Inquirer

Komen Charity Under Microscope for Funding, Science Reuters

The Fight Against Cancer - And Abortion? Salon.com

Susan G. Komen For the Cure defunds Planned Parenthood. In Deep with Angie Coiro

Amid Breast Cancer Month, Is there Pink Fatigue? NPR's All Things Considered

How is Breast Cancer Culture Undermining Women's Health? America’s Radio News Network

Pink Ribbon Culture and Breast Cancer The Kojo Nnamdi Show

The Big Business of Breast Cancer
Marie Claire

Does Breast Cancer Awareness Month Crowd Out Other Diseases? Slate

Pink Inc. Has Many Starting to See Red The Sacramento Bee

Get Your Pink Off Ottawa Citizen

Komen Pink Ribbons Raise Green and Questions USA Today

** MORE MEDIA LINKS **
** MORE RADIO INTERVIEWS **